Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes

Detalles Bibliográficos
Autores principales: Zaccardi, Francesco, Kloecker, David E., Buse, John B., Mathieu, Chantal, Khunti, Kamlesh, Davies, Melanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
e-Letters: Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441544/
https://www.ncbi.nlm.nih.gov/pubmed/33334809
http://dx.doi.org/10.2337/dc20-2080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441544/
https://www.ncbi.nlm.nih.gov/pubmed/33334809
http://dx.doi.org/10.2337/dc20-2080

Ejemplares similares